Tailoring the dose of oral corticosteroids in people with severe asthma according to their levels of blood eosinophils can reduce the number of exacerbations, improve asthma symptoms and reduce overall steroid usage, a small Australian pilot study shows. Speaking to the limbic lead author Peter Wark from the Centre for Asthma and Respiratory Disease at ...
Biomarker helps tailor steroid treatment in severe asthma
By Nicola Garrett
13 Aug 2015